Journées d’enseignement supérieur de neurologie, Paris, 2024 von Papeix, C.

Volltext

Can we discontinue disease-modifying treatments in multiple sclerosis patients? No von Papeix, C.

Volltext

Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders von Ciron, J., Audoin, B., Bourre, B., Brassat, D., Durand-Dubief, F., Laplaud, D., Maillart, E., Papeix, C., Vukusic, S., Zephir, H., Marignier, R., Collongues, N.

Volltext

A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis von Louapre, C., Rosenzwajg, M., Golse, M., Roux, A., Pitoiset, F., Adda, L., Tchitchek, N., Papeix, C., Maillart, E., Ungureanu, A., Charbonnier-Beaupel, F., Galanaud, D., Corvol, J. C., Vicaut, E., Lubetzki, C., Klatzmann, D.

Volltext

Efficacy of rituximab in refractory neuromyelitis optica von Collongues, N, Brassat, D, Maillart, E, Labauge, P, Ouallet, JC, Carra-Dalliere, C, Moreau, T, Bourre, B, Papeix, C, Brochet, B, Audoin, B, Vukusic, S, de Seze, J, Marignier, R

Volltext

Idiopathic acute transverse myelitis: application of the recent diagnostic criteria von de Seze, J, Lanctin, C, Lebrun, C, Malikova, I, Papeix, C, Wiertlewski, S, Pelletier, J, Gout, O, Clerc, C, Moreau, C, Defer, G, Edan, G, Dubas, F, Vermersch, P

Volltext

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica von Papeix, C, Vidal, J-S, Seze, J De, Pierrot-Deseilligny, C, Tourbah, A, Stankoff, B, Lebrun, C, Moreau, T, Vermersch, P, Fontaine, B, Lyon-Caen, O, Gout, O

Volltext

Clinical, imaging and follow‐up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patients von Shor, N., Aboab, J., Maillart, E., Lecler, A., Bensa, C., Le Guern, G., Grunbaum, S., Marignier, R., Papeix, C., Heron, E., Gout, O., Savatovsky, J., Galanaud, D., Vignal, C., Touitou, V., Deschamps, R.

Volltext

A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteria von Papeix, C., Beigneux, Y., Maillart, E., Seze, J., Lubetzki, C., Vukusic, S., Collongues, N., Marignier, R.

Volltext

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset von Collongues, N, Marignier, R, Jacob, A, Leite, MI, Siva, A, Paul, F, Zephir, H, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J

Volltext

Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum von Louapre, C., Maillart, E., Roux, T., Pourcher, V., Bussone, G., Lubetzki, C., Papeix, C.

Volltext

Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal von Daelman, L, Maitrot, A, Maarouf, A, Chaunu, MP, Papeix, C, Tourbah, A

Volltext

Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study von Cabre, Philippe, Mejdoubi, M., Jeannin, S., Merle, H., Plumelle, Y., Cavillon, G., Smadja, D., Marignier, R.

Volltext

Neuromyelitis optica and pregnancy von BOURRE, B, MARIGNIER, R, FONTAINE, B, VERMERSCH, P, CONFAVREUX, C, DE SEZE, J, ZEPHIR, H, PAPEIX, C, BRASSAT, D, CASTELNOVO, G, COLLONGUES, N, VUKUSIC, S, LABAUGE, P, OUTTERYCK, O

Volltext

Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRI von Landes-Chateau, C., Levraut, M., Cohen, M., Sicard, M., Papeix, C., Cotton, F., Balcerac, A., Themelin, A., Mondot, L., Lebrun-Frenay, C.

Volltext

Neuromyelitis optica in France: A multicenter study of 125 patients von COLLONGUES, N, MARIGNIER, R, FONTAINE, B, BRASSAT, D, CLANET, M, MILH, M, PELLETIER, J, AUDOIN, B, RUET, A, LEBRUN-FRENAY, C, THOUVENOT, E, CAMU, W, ZEPHIR, H, DEBOUVERIE, M, CREANGE, A, MOREAU, T, LABAUGE, P, CASTELNOVO, G, EDAN, G, LE PAGE, E, DEFER, G, BARROSO, B, HEINZLEF, O, PAPEIX, C, GOUT, O, RODRIGUEZ, D, WIERTLEWSKI, S, LAPLAUD, D, BORGEL, F, TOURNIAIRE, P, GRIMAUD, J, BROCHET, B, VERMERSCH, P, CONFAVREUX, C, BLANC, F, DE SEZE, J, RITLENG, C, TCHIKVILADZE, M, OUTTERYCK, O, VUKUSIC, S, FLEURY, M

Volltext

A short washout period from fingolimod to anti-CD20 therapy is safe and decreases the risk of reactivation von Gassama, S., Garmendia, A., Lejeune, F.X., Boudot de la Motte, M., Louapre, C., Papeix, C., Maillart, E., Roux, T.

Volltext

Long-term follow-up of neuromyelitis optica with a pediatric onset von COLLONGUES, N, MARIGNIER, R, AUDOIN, B, THOUVENOT, E, CAMU, W, BARROSO, B, RUET, A, BROCHET, B, VERMERSCH, P, CONFAVREUX, C, DE SEZE, J, ZEPHIR, H, PAPEIX, C, FONTAINE, B, BLANC, F, RODRIGUEZ, D, FLEURY, M, VUKUSIC, S, PELLETIER, J

Volltext

MRI characteristics of MOG-Ab associated disease in adults: An update von Shor, N., Deschamps, R., Cobo Calvo, A., Maillart, E., Zephir, H., Ciron, J., Papeix, C., Durand-Dubief, F., Ruet, A., Ayrignac, X., Cohen, M., Deiva, K., Laplaud, D., Bourre, B., Audoin, B., Collongues, N., Vukusic, S., Cotton, F., Marignier, R.

Volltext

CO7.1 - Anti-CD20 et sévérité de la COVID-19 chez les patients vivants avec une sclérose en plaques dans la cohorte COVISEP: un impact différent selon la forme progressive ou récur... von Januel, E., Hajage, D., Papeix, C., Tubach, F., Louapre, C.

Volltext